Delivery Order SPE2DB20D1100-SPE2DB24FC4R1

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.96 firm fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,668.08 firm-fixed-price contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a prescription medication. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen is a large, for-profit organization that specializes in providing a wide range of pharmaceutical and medical products to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,179.07 firm fixed price contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a prescription pharmaceutical product. The delivery order was not set aside under any specific preference program. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $1,667.55 firm fixed price contract is for the delivery of Tresiba Flextouch 100 Unit/ML 3ML, a prescription diabetes medication. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order worth $1,334.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $3,574.17 firm-fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This is a $2,344.66 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products, with a period of performance through July 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a potential value of $30,469.74 and a completion date of March 8, 2024. The award is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product, valued at $2,335.30 with a completion date of March 6, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that holds an indefinite delivery contract (IDC) with DLA to deliver...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,035.95 fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical that runs through November...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC4R1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,334.04 firm-fixed-price contract is for the provision of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML pharmaceutical products, with a completion date of June 28, 2024.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific delivery order does not have a set-aside designation, indicating it was awarded through full and open competition. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical commodities.

Generated 9/26/24, 9:38 AM